Cadila Pharma launches three-dose rabies vaccine - Moneycontrol

The three-dose vaccine, named as 'ThRabis’, is a recombinant nano-particle based G protein vaccine which is prepared using Virus-like Particle technology, the company said in a release, adding that the three-dose schedule is spread over only one week.

Pharmaceutical major Cadila Pharmaceuticals on Friday announced that it has developed the worlds first novel three-dose vaccine against rabies. The three-dose vaccine, named as 'ThRabis, is a recomb… [+2108 chars]

full article...